Myong Cheol Lim

77PUBLICATIONS
279CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Oct 16, 2026
Real-World Germline Variant Landscape and Clinical Management in Korean Patients Tested for Suspected Hereditary Cancer.

|Sep 26, 2026
Effectiveness of first-line niraparib maintenance in Korean patients with advanced ovarian cancer: a multicenter retrospective cohort study.

|Jan 29, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Hyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim

|Jan 23, 2026
Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028).

Uisuk Kim, Jaekyung Bae, E Sun Paik

|Dec 11, 2025
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy.

Ji Hyun Kim, Eun Taeg Kim, Heon Jong Yoo

|Oct 29, 2025
Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis.

Sekyoung Hwang, Ji Hyun Kim, Uisuk Kim

Pageof 13

Frequent Collaborators

20 joint publications

Sang-Yoon Park

16 joint publications

Ji Hyun Kim

14 joint publications

Jae-Weon Kim

13 joint publications

Jung-Yun Lee